LLY

1,028.36

+2.17%↑

JNJ

195.27

+0.72%↑

ABBV

237.98

+3.94%↑

UNH

337.31

-1.53%↓

AZN

88.75

+0.44%↑

LLY

1,028.36

+2.17%↑

JNJ

195.27

+0.72%↑

ABBV

237.98

+3.94%↑

UNH

337.31

-1.53%↓

AZN

88.75

+0.44%↑

LLY

1,028.36

+2.17%↑

JNJ

195.27

+0.72%↑

ABBV

237.98

+3.94%↑

UNH

337.31

-1.53%↓

AZN

88.75

+0.44%↑

LLY

1,028.36

+2.17%↑

JNJ

195.27

+0.72%↑

ABBV

237.98

+3.94%↑

UNH

337.31

-1.53%↓

AZN

88.75

+0.44%↑

LLY

1,028.36

+2.17%↑

JNJ

195.27

+0.72%↑

ABBV

237.98

+3.94%↑

UNH

337.31

-1.53%↓

AZN

88.75

+0.44%↑

Search

Globus Medical Inc (Class A)

Atidarymo kaina

SektoriusSveikatos priežiūra

84.75 -1.26

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

84.03

Max

86.07

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-84M

119M

Pardavimai

24M

769M

P/E

Sektoriaus vid.

27.948

105.69

Pelnas, tenkantis vienai akcijai

1.18

Pelno marža

15.469

Darbuotojai

5,300

EBITDA

22M

215M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+4.54% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.3B

12B

Ankstesnė atidarymo kaina

86.01

Ankstesnė uždarymo kaina

84.75

Naujienos nuotaikos

By Acuity

37%

63%

136 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Globus Medical Inc (Class A) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-12 21:55; UTC

Uždarbis

Xero Beats 1st Half Profit Expectations Despite Melio Margin Hit

2025-11-12 21:34; UTC

Uždarbis

Cisco Systems Boosts Fiscal Year Outlook as 1Q Profit, Revenue Rise

2025-11-12 23:44; UTC

Rinkos pokalbiai

Nikkei May Trade in Range Amid Caution Over U.S. Econ -- Market Talk

2025-11-12 23:38; UTC

Rinkos pokalbiai

Gold Steady Ahead of Expected End to U.S. Government Shutdown -- Market Talk

2025-11-12 23:13; UTC

Uždarbis

Samsung Fire & Marine Insurance 3Q Net Profit Largely Met FactSet-Compiled Consensus

2025-11-12 23:13; UTC

Uždarbis

Samsung Fire & Marine Insurance 3Q Net KRW538.50B Vs. Net KRW554.56B >000810.SE

2025-11-12 23:13; UTC

Uždarbis

Samsung Fire & Marine Insurance 3Q Oper Pft KRW664.06B Vs. Pft KRW717.46B >000810.SE

2025-11-12 23:13; UTC

Uždarbis

Samsung Fire & Marine Insurance 3Q Rev KRW5.732T Vs. KRW5.326T >000810.SE

2025-11-12 22:30; UTC

Rinkos pokalbiai
Uždarbis

Firefly Aerospace Sets Plan for Next Launch After Explosion -- Market Talk

2025-11-12 22:18; UTC

Uždarbis

Cisco Systems Boosts Outlook on AI-Driven Demand -- Update

2025-11-12 22:12; UTC

Rinkos pokalbiai

Bank of Canada Rate Hikes Could Start in 2H 2026 -- Market Talk

2025-11-12 22:05; UTC

Uždarbis

Pan American Silver: Campbell Succeeded Steve Busby >PAAS

2025-11-12 22:04; UTC

Uždarbis

Pan American Silver Named Scott Campbell as Operating Chief on Oct. 20

2025-11-12 22:04; UTC

Uždarbis

Pan American Silver 3Q Adj EPS 48c >PAAS

2025-11-12 22:04; UTC

Uždarbis

Pan American Silver 3Q Rev $884.4M >PAAS

2025-11-12 22:04; UTC

Uždarbis

Pan American Silver 3Q EPS 45c >PAAS

2025-11-12 22:03; UTC

Uždarbis

Manulife Financial: 3Q Book Value Per Common Shr C$26.07 >MFC.T

2025-11-12 22:02; UTC

Uždarbis

Manulife Financial 3Q Net C$1.8B >MFC

2025-11-12 22:02; UTC

Uždarbis

Manulife Financial 3Q Adj EPS C$1.16 >MFC

2025-11-12 22:02; UTC

Uždarbis

Manulife Financial 3Q EPS C$1.02 >MFC

2025-11-12 21:53; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel: Sale Strengthens Focus on Own Growth Investments

2025-11-12 21:53; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel Says Deal Subject to Indian Regulatory Approvals

2025-11-12 21:53; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel Estimates Net Profit After Tax on Sale of A$70 Million

2025-11-12 21:53; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel Expects Net Proceeds After Taxes, Fees of A$179 Million in 2H FY26

2025-11-12 21:52; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel: Tata BlueScope Steel JV a Provider of Coated, Painted Steel Products in India

2025-11-12 21:51; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel Agrees to Sell 50% Stake in Tata BlueScope Steel Joint Venture to Tata Steel

2025-11-12 21:50; UTC

Rinkos pokalbiai
Uždarbis

Basic Materials Roundup: Market Talk

2025-11-12 21:49; UTC

Uždarbis

Cisco Stock Climbs as Earnings Beat Expectations Amid Strong AI Demand -- Barrons.com

2025-11-12 21:48; UTC

Uždarbis

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares. -- Barrons.com

2025-11-12 21:40; UTC

Uždarbis

Xero Beats 1H Profit Expectations Despite Melio Margin Hit

Akcijų palyginimas

Kainos pokytis

Globus Medical Inc (Class A) Prognozė

Kainos tikslas

By TipRanks

4.54% į viršų

12 mėnesių prognozė

Vidutinis 88.8 USD  4.54%

Aukščiausias 114 USD

Žemiausias 64 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Globus Medical Inc (Class A) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

13 ratings

9

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

72.18 / 73.07Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

136 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat